Squarepoint Ops LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 147 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$306,963
-20.4%
27,481
+188.3%
0.00%
-50.0%
Q1 2023$385,515
-40.0%
9,533
-31.0%
0.00%
-33.3%
Q4 2022$642,813
+138.1%
13,818
+165.1%
0.00%
+200.0%
Q3 2022$270,000
+24.4%
5,213
+5.9%
0.00%0.0%
Q2 2021$217,000
-10.0%
4,924
-6.6%
0.00%
-66.7%
Q3 2020$241,000
-26.5%
5,271
-19.4%
0.00%
-40.0%
Q2 2020$328,000
-70.5%
6,537
-69.8%
0.01%
-82.1%
Q1 2020$1,111,000
+50.7%
21,611
+81.0%
0.03%
+600.0%
Q4 2019$737,000
-64.4%
11,937
-65.4%
0.00%
-78.9%
Q3 2019$2,073,000
+241.5%
34,498
+379.5%
0.02%
+216.7%
Q2 2019$607,000
-38.9%
7,195
-30.8%
0.01%
-45.5%
Q1 2019$994,000
-37.0%
10,404
-53.3%
0.01%
-38.9%
Q4 2018$1,579,000
+79.2%
22,291
+116.3%
0.02%
+63.6%
Q3 2018$881,000
-57.7%
10,304
-42.7%
0.01%
-60.7%
Q2 2018$2,085,000
+6.6%
17,990
-25.6%
0.03%
-9.7%
Q1 2018$1,956,000
+25.9%
24,177
-8.6%
0.03%
+14.8%
Q4 2017$1,553,000
+473.1%
26,466
+226.8%
0.03%
+145.5%
Q4 2016$271,000
+14.8%
8,098
-8.9%
0.01%
-31.2%
Q3 2016$236,000
+0.4%
8,885
+11.1%
0.02%
-11.1%
Q1 2016$235,000
-43.2%
8,000
-36.2%
0.02%
-60.0%
Q4 2015$414,00012,5320.04%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders